The overall pattern of increased T-cell activity, including differentiation to cytotoxic Th1 and Th17 cells promoted by IL-6, is a key immunopathogenic similarity between IBD and GIBD [65]. This evidence concerns the gene IL6 and inflammatory bowel disease.